Search Our Site

News tagged with:

"heart-failure"

Cardiovascular disease costs will exceed $1 Trillion by 2035

Nearly half of Americans will develop pre-existing cardiovascular disease conditions, analysis by RTI International shows   RESEARCH TRIANGLE PARK, NC – A new study projects that by 2035, cardiovascular disease, the most costly and prevalent killer, if left unchecked, will place a crushing economic and health burden on the nation’s financial and health care systems.... Read More »

Read More →

Nearly half of Americans will develop pre-existing cardiovascular disease conditions, analysis by RTI International shows   RESEARCH TRIANGLE PARK, NC – A new study projects that by 2035, cardiovascular disease, the most costly and prevalent killer, if left unchecked, will place a crushing economic and health burden on the nation’s financial and health care systems…. Read More »

[...]

Read More

Flabby heart keeps pumping with squeeze from robotic sleeve

WASHINGTON (AP) – Scientists are developing a robotic sleeve that can encase a flabby diseased heart and gently squeeze to keep it pumping. So far it’s been tested only in animals, improving blood flow in pigs. But this “soft robotic” device mimics the natural movements of a beating heart, a strategy for next-generation treatments of... Read More »

Read More →

WASHINGTON (AP) – Scientists are developing a robotic sleeve that can encase a flabby diseased heart and gently squeeze to keep it pumping. So far it’s been tested only in animals, improving blood flow in pigs. But this “soft robotic” device mimics the natural movements of a beating heart, a strategy for next-generation treatments of… Read More »

[...]

Read More

FDA approves new drug to treat heart failure

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which... Read More »

Read More →

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which… Read More »

[...]

Read More
Categories
Archives